SS
Stephen Sherwin
OtherActiveVenture Partner at Third Rock Ventures
58
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Stephen Sherwin.
Investment Thesis & Strategy
Stephen Sherwin, as a Venture Partner at Third Rock Ventures, invests in various stages of biotech companies, focusing on those with groundbreaking scientific discoveries and the potential to address significant unmet medical needs.
Portfolio Companies
Selected investments from their portfolio of 58 companies
A
Allena Pharmaceuticals
Other · , 0
I
Inc.
Other · Seed, 0
M
Maze Therapeutics
Other · , 0
N
Neon Therapeutics
Other · , 0
T
TARIS Biomedical
Other · , 0
N
NinePoint Medical
Other · , 0
A
Asher Bio
Other · , 0
M
MyoKardia
Other · , 0
T
Thrive Earlier Detection
Other · , 0
C
Celsius Therapeutics
Other · , 0
I
Igenica
Other · , 0
C
Cedilla Therapeutics
Other · , 0
Frequently Asked Questions
Stephen Sherwin focuses on Seed stage investments.
Related Investors
Peter Segall
United States, United States · 94 deals
Michael Abramson
United States, United States · 91 deals
Dan Morehead
United States, United States · 90 deals
Isaac Ciechanover
United States, United States · 79 deals
Ryan Schuler
United States, United States · 61 deals
Artem Barsukov
United States, United States · 50 deals